<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Struct Biol</journal-id><journal-id journal-id-type="iso-abbrev">BMC Struct. Biol</journal-id><journal-title-group><journal-title>BMC Structural Biology</journal-title></journal-title-group><issn pub-type="epub">1472-6807</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4546082</article-id><article-id pub-id-type="pmid">26289431</article-id><article-id pub-id-type="publisher-id">42</article-id><article-id pub-id-type="doi">10.1186/s12900-015-0042-4</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Structural characterization of the carbohydrate-binding module of NanA sialidase, a pneumococcal virulence factor</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Lei</given-names></name><address><email>ly10@st-andrews.ac.uk</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Connaris</surname><given-names>Helen</given-names></name><address><phone>+44-1334-467257</phone><email>hc6@st-andrews.ac.uk</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Potter</surname><given-names>Jane A.</given-names></name><address><email>jap7@st-andrews.ac.uk</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Taylor</surname><given-names>Garry L.</given-names></name><address><email>glt2@st-andrews.ac.uk</email></address><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1">Biomedical Sciences Research Complex, University of St Andrews, St Andrews, Fife KY16 9ST UK </aff></contrib-group><pub-date pub-type="epub"><day>20</day><month>8</month><year>2015</year></pub-date><pub-date pub-type="pmc-release"><day>20</day><month>8</month><year>2015</year></pub-date><pub-date pub-type="collection"><year>2015</year></pub-date><volume>15</volume><elocation-id>15</elocation-id><history><date date-type="received"><day>2</day><month>7</month><year>2015</year></date><date date-type="accepted"><day>11</day><month>8</month><year>2015</year></date></history><permissions><copyright-statement>&#169; Yang et al. 2015</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p><italic>Streptococcus pneumoniae</italic> Neuraminidase A (NanA) is a multi-domain protein anchored to the bacterial surface. Upstream of the catalytic domain of NanA is a domain that conforms to the sialic acid-recognising CBM40 family of the CAZY (carbohydrate-active enzymes) database. This domain has been identified to play a critical role in allowing the bacterium to promote adhesion and invasion of human brain microvascular endothelial cells, and hence may play a key role in promoting bacterial meningitis. In addition, the CBM40 domain has also been reported to activate host chemokines and neutrophil recruitment during infection.</p></sec><sec><title>Results</title><p>Crystal structures of both apo- and holo- forms of the NanA CBM40 domain (residues 121 to 305), have been determined to 1.8&#160;&#197; resolution. The domain shares the fold of other CBM40 domains that are associated with sialidases. When in complex with &#945;2,3- or &#945;2,6-sialyllactose, the domain is shown to interact only with the terminal sialic acid. Significantly, a deep acidic pocket adjacent to the sialic acid-binding site is identified, which is occupied by a lysine from a symmetry-related molecule in the crystal. This pocket is adjacent to a region that is predicted to be involved in protein-protein interactions.</p></sec><sec><title>Conclusions</title><p>The structural data provide the details of linkage-independent sialyllactose binding by NanA CBM40 and reveal striking surface features that may hold the key to recognition of binding partners on the host cell surface. The structure also suggests that small molecules or sialic acid analogues could be developed to fill the acidic pocket and hence provide a new therapeutic avenue against meningitis caused by <italic>S. pneumoniae</italic>.</p></sec></abstract><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; The Author(s) 2015</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Background</title><p><italic>Streptococcus pneumoniae</italic> is a human pathogen responsible for respiratory tract infections, septicaemia and meningitis. Several virulence factors contribute to colonization and early infection processes [<xref ref-type="bibr" rid="CR1">1</xref>]. Sialidases from pathogenic bacteria are considered as key virulence factors, as they remove sialic acid from host cell surface glycans, unmasking certain receptors to facilitate bacterial adherence and colonization. All <italic>S. pneumoniae</italic> clinical isolates investigated to date possess prominent sialidase activities. Three sialidases, NanA, NanB and NanC, are encoded by <italic>S. pneumoniae</italic> genomes. A study of sialidase genes in clinical pneumococcal isolates identified <italic>nanA, nanB</italic> and <italic>nanC</italic> to be present in 100&#160;%, 96&#160;% and 51&#160;% of these strains, respectively [<xref ref-type="bibr" rid="CR2">2</xref>]. Pneumococcal strains with knockouts of <italic>nanA</italic> or <italic>nanB,</italic> and studied in mouse models, show that both proteins are essential to <italic>S. pneumoniae</italic> infection of the respiratory tract and sepsis [<xref ref-type="bibr" rid="CR3">3</xref>]. NanA, specifically, has been shown to play an important role in host-pneumococcal interactions in the upper respiratory tract [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>], and is involved in biofilm formation [<xref ref-type="bibr" rid="CR6">6</xref>]. It has also been shown to desialylate competing bacteria such as <italic>Neisseria meningitidis</italic> and <italic>Haemophilus influenzae,</italic> potentially giving <italic>S. pneumoniae</italic> an advantage in shared bacterial niches [<xref ref-type="bibr" rid="CR7">7</xref>]. Furthermore, the NanA from <italic>S. pneumoniae</italic> has also been shown to promote inflammation by disrupting sialic acid based recognition of CD24 by SiglecG in mice (the equivalent of SIGLEC10 in humans) [<xref ref-type="bibr" rid="CR8">8</xref>].</p><p>From amino acid sequence comparison of bacterial sialidases, NanA is modular by nature and its domain organisation is similar to other known bacterial sialidases (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>). The enzyme contains a catalytic domain flanked by an N-terminal carbohydrate-binding domain (CBM) that is downstream of a signal sequence, followed by a region of predicted disorder. At the C-terminus, there is a region rich in proline, glycine, threonine and serine containing a sequence of 20 amino acids repeated three times contiguously followed by an LPXTG anchor sequence. Subsequent analysis of multiple pneumococcal strains showed that the <italic>nanA</italic> gene is highly diverse, mainly in truncations in the C-terminal region, but that the N-terminal CBM and catalytic domain are conserved [<xref ref-type="bibr" rid="CR9">9</xref>]. Two studies have reported the importance of NanA in allowing <italic>S. pneumoniae</italic> to adhere to and invade the blood&#8211;brain-barrier (BBB), through the use of human brain microvascular endothelial cells (hBMECs). In particular the N-terminal CBM domain (described in the study as a laminin G-like domain) was found to be the critical determinant of this event [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. Both of these studies showed that the catalytic activity of NanA only played a minor role in the adhesion/invasion event, with one study showing that the N-terminal CBM was also involved in the induction of neutrophil chemo-attractants IL-8, CXCL-1 and CXCL-2 [<xref ref-type="bibr" rid="CR11">11</xref>].<fig id="Fig1"><label>Fig. 1</label><caption><p>Schematic of the NanA domains</p></caption><graphic xlink:href="12900_2015_42_Fig1_HTML" id="MO1"/></fig></p><p>We recently cloned the N-terminal CBM domain of NanA (residues 121&#8211;305) and carried out a glycan array screen that showed the domain binds to sialic acid [<xref ref-type="bibr" rid="CR12">12</xref>], and as such is a Family 40 CBM as defined in the CAZY database [<xref ref-type="bibr" rid="CR13">13</xref>]. We have also engineered multivalent forms of this domain, designed to adhere with high affinity to sialic acid receptors in the respiratory tract, and have shown that they prevent infection from influenza viruses in a mouse model. Preliminary analysis of immunomodulators during this influenza study supports the ability of this domain to stimulate the immune system in mice, specifically IL-1&#946;, MIP-2 (the mouse homolog of IL-8), IFN-&#947; and TNF-&#945; [<xref ref-type="bibr" rid="CR12">12</xref>].</p><p>To date, only the catalytic domain of NanA has been studied structurally, and is the subject of small molecule inhibitor studies [<xref ref-type="bibr" rid="CR14">14</xref>&#8211;<xref ref-type="bibr" rid="CR16">16</xref>]. Here we describe the crystal structure of the <italic>S. pneumoniae</italic> NanA CBM40 domain, hereafter named <italic>Sp</italic>CBM. Crystal structures of <italic>Sp</italic>CBM, complexed with &#945;2,3-sialyllactose (Neu5Ac-&#945;2,3-Gal-&#946;1,4-Glc, from here on referred to as 3&#8217;SL) and &#945;2,6-sialyllactose (Neu5Ac-&#945;2,6-Gal-&#946;1,4-Glc, from here on referred to as 6&#8217;SL) are also described. The structure of <italic>Sp</italic>CBM is compared to other known CBM40 structures showing that it shares a similar fold. In contrast to the other CBM40 domains, <italic>Sp</italic>CBM has a deep water-filled pocket adjacent to the N-acetyl moiety of sialic acid and surrounded by a positively charged surface. In the crystal structures, the acidic pocket is partially occupied by a lysine residue from a symmetry-related molecule. The structure of <italic>Sp</italic>CBM suggests that it may recognise a second receptor that may be responsible for the induction of chemokines, and the BBB invasion event.</p></sec><sec id="Sec2" sec-type="results"><title>Results</title><sec id="Sec3"><title>Structure overview</title><p>All residues (from Val121 to Ser305) of the expressed CBM were clearly identifiable in the <italic>Sp</italic>CBM crystal structure. As shown in Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>, the native structure constitutes a central &#946;-sandwich (comprising one antiparallel &#946;-sheet containing five-strands and a second antiparallel &#946;-sheet containing six-strands), a &#946;-hairpin on one side of the sandwich, an &#945;-helix present between the &#946;-sheets and a C-terminal &#945;-helix packing against the &#946;-sandwich. When compared to other CBM40 structures, <italic>Sp</italic>CBM is structurally homologous to CBM40 modules from <italic>C. perfringens</italic> NanJ [PDB ID: 2&#160;V73]; RMSD 1.7&#160;&#197; for 169 C&#945;&#8217;s [<xref ref-type="bibr" rid="CR17">17</xref>], <italic>S. pneumoniae</italic> NanB [PDB ID: 2VW0]; RMSD 2.0&#160;&#197; for 170 C&#945;&#8217;s [<xref ref-type="bibr" rid="CR18">18</xref>], <italic>M. decora</italic> NanL [PDB ID: 2SLI]; RMSD 2.0&#160;&#197; for 176 C&#945;&#8217;s [<xref ref-type="bibr" rid="CR19">19</xref>], and <italic>V. cholerae</italic> NanH [PDB ID: 1W0P]; RMSD 3.1&#160;&#197; for 134 C&#945;&#8217;s [<xref ref-type="bibr" rid="CR20">20</xref>]. The superposition of <italic>Sp</italic>CBM with these structurally homologous domains is shown in Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>.<fig id="Fig2"><label>Fig. 2</label><caption><p>Overall structure of the <italic>Sp</italic>CBM. Cartoon representation of the <italic>Sp</italic>CBM in two orientations, coloured in rainbow colours from blue at the N-terminus to red at the C-terminus</p></caption><graphic xlink:href="12900_2015_42_Fig2_HTML" id="MO2"/></fig><fig id="Fig3"><label>Fig. 3</label><caption><p>Stereo view of the cartoon representation of the superimposition of <italic>Sp</italic>CBM with other CBM40 family members. <bold>a</bold>
<italic>Sp</italic>CBM is shown in green, NanB-CBM is shown in blue, NanJ-CBM is shown in yellow and NanL-CBM is shown in pink. <bold>b</bold> Superimposition of <italic>Sp</italic>CBM with NanH-CBM. NanH-CBM is shown in grey</p></caption><graphic xlink:href="12900_2015_42_Fig3_HTML" id="MO3"/></fig></p></sec><sec id="Sec4"><title>Ligand binding site</title><p>For the complexed structures, both 3&#8217;SL and 6&#8217;SL were co-crystallized with <italic>Sp</italic>CBM. There are no significant conformational changes between the apo <italic>Sp</italic>CBM structure and the complexed structure, and superimposition of the apo and holo structures gives an RMSD of 0.48&#160;&#197; over all C&#945; atoms for both 3&#8217;SL and 6&#8217;SL. Difference electron-density maps of both 3&#8217;SL and 6&#8217;SL molecules, in complex with <italic>Sp</italic>CBM, are clearly defined (Fig.&#160;<xref rid="Fig4" ref-type="fig">4</xref>), particularly the sialic acid moiety of each sialoside. In the 3&#8217;SL and 6&#8217;SL complexes, the protein structures are highly similar, giving an RMSD of 0.06&#160;&#197; for all of the C&#945; atoms while the sialic acid moieties of the ligands are completely superimposable. The lactose moieties of the 3&#8217;SL and 6&#8217;SL, however, point in opposite directions (Fig.&#160;<xref rid="Fig4" ref-type="fig">4a</xref> &amp; b). In 3&#8217;SL, lactose does not interact with the protein, although O6 of the glucose moiety interacts with O9 of sialic acid. In 6&#8217;SL, glucose O6 interacts with the side chain of Asp180. For both ligands, the lactose B-factors are significantly higher than the corresponding sialic acid moiety.<fig id="Fig4"><label>Fig. 4</label><caption><p>3&#8217;SL and 6&#8217;SL co-complexed with <italic>Sp</italic>CBM. <bold>a</bold> Stereo view of F<sub>o</sub>-F<sub>c</sub> map of 3&#8217;SL co-complex contoured at 2.5&#963; level. <bold>b</bold> Stereo view of F<sub>o</sub>-F<sub>c</sub> map of 6&#8217;SL co-complex contoured at 2.5&#963; level. <bold>c</bold> Stereo view of 3&#8217;SL (shown in spheres) bound to the <italic>Sp</italic>CBM substrate-binding site</p></caption><graphic xlink:href="12900_2015_42_Fig4_HTML" id="MO4"/></fig></p><p>For <italic>Sp</italic>CBM, the residues that are involved in the interaction are mainly donated from the concave surface formed by the &#946;-hairpin and three &#946;-strands (Fig.&#160;<xref rid="Fig4" ref-type="fig">4c</xref>). As shown in Fig.&#160;<xref rid="Fig5" ref-type="fig">5</xref>, the carboxylate group of Neu5Ac forms a bidentate interaction with Arg274, a common feature in proteins that bind sialic acid. Arg197 also interacts with one of the carboxylate oxygens of Neu5Ac. Other Neu5Ac atoms make additional interactions with <italic>Sp</italic>CBM: O4 interacts with the side chain of Glu195 as does the N5 of the acetamido group; the O10 carbonyl oxygen of the acetamido group interacts with Asn209; the glycerol O8 hydroxyl oxygen interacts with the imidazole nitrogen of Trp280. Phe167 provides a hydrophobic platform supporting the glycerol carbons (C7 to C9) that are ~4&#160;&#197; away, and also forms part of the hydrophobic pocket accommodating the acetamido methyl group. A number of water molecules are seen to bridge interactions between Neu5Ac and the protein. Details of the major interactions between <italic>Sp</italic>CBM and ligand are listed in Table&#160;<xref rid="Tab1" ref-type="table">1</xref>.<fig id="Fig5"><label>Fig. 5</label><caption><p>Stereo view of Neu5Ac binding sites of <italic>Sp</italic>CBM. 3&#8217;SL is shown in yellow carbon atoms and waters are shown in magenta. <italic>Sp</italic>CBM residues that are involved in the interaction are shown in stick representation with green carbon atoms. Hydrogen bonds are shown as black dotted lines</p></caption><graphic xlink:href="12900_2015_42_Fig5_HTML" id="MO5"/></fig><table-wrap id="Tab1"><label>Table 1</label><caption><p>Interactions between <italic>Sp</italic>CBM and 3&#8217;SL. Intermolecular hydrogen bonds between <italic>Sp</italic>CBM and 3&#8217;SL are listed. Water molecules bound to 3&#8217;SL are also detailed</p></caption></table-wrap></p></sec><sec id="Sec5"><title>Acidic cavity adjacent to sialic acid binding site</title><p>A striking feature of the protein is a deep, negatively charged cavity adjacent to the sialic acid binding site (Fig.&#160;<xref rid="Fig6" ref-type="fig">6a</xref>). This pocket is formed by four residues (Glu195, Gln203, Asn207 and Asn209), and is occupied by a lysine from a symmetry-related molecule (Fig.&#160;<xref rid="Fig6" ref-type="fig">6b</xref>). Interestingly, a region immediately adjacent to this pocket and to the sialic acid binding site is highlighted by the results of the meta-PPISP server as a likely protein interaction site (Fig.&#160;<xref rid="Fig7" ref-type="fig">7</xref>). No other protein binding sites on <italic>Sp</italic>CBM are predicted, and no such sites are predicted on the CBMs of NanB, NanL or NanH. NanJ CBM has a low-scoring patch in a region that overlaps with the corresponding patch on <italic>Sp</italic>CBM.<fig id="Fig6"><label>Fig. 6</label><caption><p>Potential functional cavity of <italic>Sp</italic>CBM. <bold>a</bold> The surface electrostatic view from the top of the binding site of <italic>Sp</italic>CBM and a cavity adjacent to the active site, which is occupied by a lysine from a symmetry related molecule (shown in cyan). <bold>b</bold> Close-up view of the interaction between the lysine and the protein. The solvent-accessible surface of <italic>Sp</italic>CBM is coloured based on the electrostatic potential from &#8722;7 (red) to +7 (blue<italic>)</italic> kT/e, calculated using the APBS tool in PyMOL [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR35">35</xref>]</p></caption><graphic xlink:href="12900_2015_42_Fig6_HTML" id="MO6"/></fig><fig id="Fig7"><label>Fig. 7</label><caption><p>Prediction of protein-protein interaction site. The <italic>Sp</italic>CBM surface is coloured according to meta-PPISP score. Residues are coloured from green (low propensity for protein binding) to red (high propensity). The sialic acid moiety of 3&#8217;SL is shown in stick representation with purple carbon atoms</p></caption><graphic xlink:href="12900_2015_42_Fig7_HTML" id="MO7"/></fig></p></sec><sec id="Sec6"><title>Kinetics and binding affinity of <italic>Sp</italic>CBM interaction with 3&#8217;SL</title><p>A sensogram showing the association and dissociation of <italic>Sp</italic>CBM binding to 3&#8217;SL is shown in Fig.&#160;<xref rid="Fig8" ref-type="fig">8a</xref>. The kinetic parameters for the interaction based on global fitting of raw data using a 1:1 (Langmuir) binding model gave a K<sub><italic>D</italic></sub> value of 1.8&#8201;&#177;&#8201;0.13&#160;&#956;M and R<sup>2</sup> of 0.99 (data not shown). As equilibrium was also observed with the different <italic>Sp</italic>CBM concentrations, a K<sub><italic>D</italic></sub> value of 1.8&#8201;&#177;&#8201;0.12&#160;&#956;M was determined from steady state binding by plotting the response at equilibrium against <italic>Sp</italic>CBM concentration (Fig.&#160;<xref rid="Fig8" ref-type="fig">8b</xref>).<fig id="Fig8"><label>Fig. 8</label><caption><p>Bio-layer Interferometry. Association of <italic>Sp</italic>CBM with 3&#8217;SL immobilized to a probe via a biotin linkage as measured using bio-layer interferometry. <bold>a</bold> Sensogram showing the response units against increasing concentrations of <italic>Sp</italic>CBM. <bold>b</bold> Steady-state binding of <italic>Sp</italic>CBM-3&#8217;SL interaction determined by plotting the response at equilibrium against <italic>Sp</italic>CBM concentration and globally fitted using a 1:1 (Langmuir) binding model</p></caption><graphic xlink:href="12900_2015_42_Fig8_HTML" id="MO8"/></fig></p></sec></sec><sec id="Sec7" sec-type="discussion"><title>Discussion</title><p>CBM40 domains have been described structurally for other sialidases from <italic>Vibrio cholerae</italic> NanH [<xref ref-type="bibr" rid="CR20">20</xref>], <italic>Clostridium perfringens</italic> NanJ [<xref ref-type="bibr" rid="CR17">17</xref>], <italic>S. pneumoniae</italic> NanB [<xref ref-type="bibr" rid="CR18">18</xref>] and <italic>Macrobdella decora</italic> NanL [<xref ref-type="bibr" rid="CR19">19</xref>], with sialic acid binding only visualised in the first two. The CBM40 domains all share a common lectin &#946;-sandwich fold with two antiparallel &#946;-sheets containing five and six strands, in addition to other secondary structural elements. The sialic acid binding site is located in the concave surface of the five-stranded sheet, although the nature of the ligand interactions in the sialic acid complexes with <italic>V. cholerae</italic> NanH and <italic>C. perfringens</italic> NanJ are quite different and the binding sites are at different locations on the concave surface.</p><p>In their description of <italic>C. perfringens</italic> NanJ, Boraston <italic>et al.</italic> pointed out that there appear to be two subfamilies within the CBM40 family, one typified by <italic>C. perfringens</italic> NanJ and the other by <italic>V. cholerae</italic> NanH [<xref ref-type="bibr" rid="CR17">17</xref>]. The structure of <italic>Sp</italic>CBM confirms that it belongs to the subfamily that includes <italic>C. perfringens</italic> NanJ and also <italic>S. pneumoniae</italic> NanB and <italic>M. decora</italic> NanL CBMs.</p><p>Previous reports mentioned that certain sialic acid binding residues from <italic>C. perfringens</italic> NanJ CBM (namely Glu79 and Arg81) were conserved in closely related CBMs from <italic>S. pneumoniae</italic> NanB and <italic>M. decora</italic> NanL but differed in NanA CBM. However, an alignment based on the <italic>Sp</italic>CBM structure reveals that these residues are, in fact, conserved and correspond to NanA residues Glu195 and Arg197. Other residues in the immediate area (Arg274 and Tyr182) are also conserved and form very similar interactions as Arg151 and Tyr66 in NanJ. In <italic>S. pneumoniae</italic> NanB, residues corresponding to NanA Glu195, Arg197, Arg274 and Tyr182 are conserved and adopt very similar positions to that of NanA, suggesting that NanB is likely to bind sialic acid in a similar manner.</p><p>The binding mode in the region of the glycerol moiety is somewhat different in NanJ CBM and <italic>Sp</italic>CBM. In <italic>Sp</italic>CBM, a hydrogen bond is formed between Trp280 and the C-7 hydroxyl, whereas the corresponding residue in NanJ (Tyr158) cannot make this interaction, instead forming a different H-bond to the glycerol group via Asn156. The space filled by this Asn side chain, along with the adjacent residue Tyr155, is not occupied by any residues in the corresponding area of <italic>Sp</italic>CBM or NanB, creating a more open binding pocket in the streptococcal proteins.</p><p>From binding affinity analysis, the dissociation constant, K<sub><italic>D</italic></sub> for <italic>Sp</italic>CBM-3&#8217;SL interaction was found to be in the affinity range similar to that measured for the isolated CBM40 from <italic>V. cholerae</italic> NanH interacting with 3&#8217;SL (1.8&#160;&#956;M) as determined by Surface Plasmon Resonance (SPR) [<xref ref-type="bibr" rid="CR21">21</xref>]. This suggests that the sialic acid binding pocket of both CBM40s may be similar. On examination of the residues involved in sialic acid binding by <italic>Vc</italic>CBM [<xref ref-type="bibr" rid="CR20">20</xref>], both CBM40s involve a comparable number of direct and water-mediated interactions that target the sialic acid moiety alone, despite the overall topology of the binding sites being different between them.</p><p>Besides the classic function of binding to sialic acid, NanA was reported to enhance the <italic>S. pneumoniae</italic> interaction with human brain microvascular endothelial cells (hBMECs) via an adhesin function of NanA-CBM, which can potentially facilitate the entry of bacterial pathogens into the central nervous system (CNS), even with little contribution of the sialidase activity [<xref ref-type="bibr" rid="CR10">10</xref>]. However, it is still not completely clear which receptor in the hBMECs is important for this process, and how it could be recognized by NanA-CBM. In the current study, the surface electrostatic view shows that there is a deep, negatively charged cavity with positively charged surface next to the sialic binding site (Fig.&#160;<xref rid="Fig6" ref-type="fig">6a</xref>), which is not present in the other family 40 CBMs. Of the four amino acids that form the cavity, only Glu195 is conserved, whereas Gln203, Asn207 and Asn209 are present in a region of sequence that exhibits low homology in family 40 CBMs, suggesting that this surface feature is exclusive to <italic>S. pneumoniae</italic> NanA. The four residues interact with a lysine from a symmetry related molecule (Fig.&#160;<xref rid="Fig6" ref-type="fig">6b</xref>). Therefore, it is possible that this region is important for <italic>S. pneumoniae</italic> NanA CBM interaction with a host cell receptor. This proposed interaction site for a binding partner for NanA CBM is supported by the output of the metaPPISP web server, which combines results from three different methods for predicting protein-protein interaction sites. The predicted region lies directly adjacent to the sialic acid binding site and the acidic pocket.</p></sec><sec id="Sec8" sec-type="conclusion"><title>Conclusions</title><p>In summary, we have determined the structure of the isolated form of CBM from <italic>S. pneumoniae</italic> NanA, which has been identified as a Family 40 CBM due to its ability to bind the terminal sialic acid of glycoconjugates. Our findings suggest that this domain may enhance the virulence of NanA by targeting and binding to a variety of linkage-independent sialic acid receptors that line the surface of respiratory epithelial cells. Further experiments to determine the NanA binding partner(s) are ongoing. The <italic>Sp</italic>CBM domain, in addition to showing promise as a bio-therapeutic against respiratory pathogens [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR22">22</xref>], is a potential drug target and may be exploited as part of a combinatorial drug design approach to inhibit NanA attachment and catalysis.</p></sec><sec id="Sec9" sec-type="materials|methods"><title>Methods</title><sec id="Sec10"><title>Cloning, expression, and purification</title><p>The gene encoding the <italic>Sp</italic>CBM domain from <italic>S. pneumoniae</italic> NanA (UniProt: P62575) was generated by the polymerase chain reaction (PCR) using the following primers 5&#8217;-GGCT<bold>CCATGG</bold>TGATAGAAAAAGAAGATG-3&#8217; and 5&#8217;-GCA<bold>CTCGAG</bold>TCATTTAAAAAGTTGACTACG-3&#8217; (<italic>Nco</italic>I and <italic>Xho</italic>I restriction sites in bold) and pQE30 vector containing the <italic>nanA</italic> sialidase gene as template. The PCR fragment was purified using a Gel Extraction Kit (QIAGEN) prior to ligation into an appropriately digested pEHISGFPTEV vector [<xref ref-type="bibr" rid="CR23">23</xref>]. The construct was propagated in <italic>Escherichia coli</italic> DH5&#945; cells with positive colonies identified by colony PCR. The DNA sequence was confirmed by sequencing (The Sequencing Service, University of Dundee, UK), prior to transforming <italic>E. coli</italic> BL21 (DE3) expression strain (Novagen) for protein production.</p><p>Expression of <italic>Sp</italic>CBM was achieved by inoculating Luria Broth (LB) medium containing 50&#160;&#956;g/ml kanamycin with a single colony and incubating at 37&#160;&#176;C until cultures reached an absorbance at 600&#160;nm (<italic>A</italic><sub>600</sub>) of 0.6. Cultures were subjected to heat shock at 42&#160;&#176;C for 20&#160;minutes prior to cooling to 25&#160;&#176;C and induced with isopropyl thio-&#946;-D-galactopyranoside (IPTG, 0.5&#160;mM final concentration) to induce expression of <italic>Sp</italic>CBM. Cultures were left to incubate further overnight at 18&#160;&#176;C before harvesting by centrifugation at 10,000&#8201;<italic>g</italic> for 20&#160;min. Cell pellets were resuspended in phosphate-buffered saline (PBS; 20&#160;mM sodium phosphate, 150&#160;mM sodium chloride, pH7.4) containing 10&#160;mM imidazole and 300&#160;mM sodium chloride with DNase I (Sigma, final concentration 20&#160;&#956;g/ml) and EDTA-free protease inhibitor tablets (one tablet per 50&#160;ml extract, Roche Diagnostics). The cell suspension was lysed by sonication to disrupt cells then subjected to centrifugation at 40,000&#8201;<italic>g</italic> for 30&#160;min at 4&#160;&#176;C to remove cell debris. Clarified supernatants were collected and filtered with a 0.2&#160;&#956;m pore size syringe-driven filter before further protein purification.</p><p>The soluble cell extract was initially loaded onto a 20&#160;ml HisPrep FF 16/10 column (GE Healthcare) equilibrated in PBS containing 10&#160;mM imidazole and 300&#160;mM sodium chloride. The column was then washed with PBS buffer containing 20&#160;mM imidazole and 300&#160;mM NaCl before eluting bound protein using the PBS/NaCl buffer supplemented with 250&#160;mM imidazole. Eluted fractions were then treated with TEV protease overnight to remove the His-GFP tag. Cleaved proteins were further purified by re-applying to the 20&#160;ml HisPrep FF 16/10 column. The collected flow through was concentrated before performing size exclusion chromatography using a HiPrep 26/60 Sephacryl S-200 HR column (GE Healthcare), which was pre-equilibrated in 20&#160;mM sodium citrate, pH6.0 containing 50&#160;mM sodium chloride. Fractions from the observed peaks were analyzed separately by SDS-PAGE gel. Protein identity and integrity were confirmed by mass spectrometry (BSRC Mass Spectrometry and Proteomics Facility, University of St Andrews). Purified <italic>Sp</italic>CBM was collected, concentrated and stored at &#8722;80&#160;&#176;C for future use.</p></sec><sec id="Sec11"><title>Bio-Layer Interferometry (BLI)</title><p>The binding affinity assay of <italic>Sp</italic>CBM to 3&#8217;SL was performed using the ForteBio Octet RED384 system (ForteBio). Assays were performed in black 96 wells plates (Nunc&#8482; F96 MicroWell&#8482; plate, Thermo Scientific) using PBS containing 0.002&#160;% Tween-20 as running buffer at 25&#160;&#176;C. Super streptavidin-coated (SSA) biosensor tips (ForteBio) were pre-hydrated in 200&#160;&#956;l running buffer for 10&#160;min followed by equilibration in PBS for 60&#160;s. Tips were non-covalently loaded with a 25&#160;&#956;g/ml solution of a multivalent biotinylated 3&#8217;SL-polyacrylamide (Glycotech) in running buffer for 300&#160;s followed by a wash of 60&#160;s in the same buffer. All sensors, including reference sensors (no ligand), were blocked with biocytin (Life Technologies) for 60&#160;s, to prevent non-specific interactions of protein to the sensor surface, followed by a further wash for 60&#160;s. Association of biotinylated ligand with <italic>Sp</italic>CBM (5-fold dilution series using a 10&#160;&#956;M stock in running buffer) was performed for 150&#160;s before dissociation of binding was performed using running buffer for 150&#160;s. All experiments were performed in triplicate. Data were processed to calculate kinetic and affinity parameters using the ForteBio software.</p></sec><sec id="Sec12"><title>Protein crystallization</title><p>Purified <italic>Sp</italic>CBM was concentrated to 33&#160;mg/ml based on the results of precrystallization assay kit screening (Hampton Research). All the subsequent crystallization experiments were done at 20&#160;&#176;C by the sitting-drop, vapour-diffusion method. Initially, commercial kits Crystal Screen, SaltRx, Index (Hampton Research), Wizard, Cryo I&amp;II (Emerald BioSystems), JCSG Suite, PACT Suite and PEGs Suite (Qiagen) were screened by a Honeybee 963 robot system (Genomic Solutions) for protein crystallization. Conditions with crystalline materials were selected for crystallization optimization. After several rounds of optimizations, the best crystals were obtained in 120&#160;mM MMT (molar ratios 1:2:2 of DL-malic acid: MES: Tris Base) buffer pH9.0, 25&#160;% (w/v) PEG1500. Crystals appeared the next day and reached their maximum size within two weeks. Structures of complexes with Neu5Ac derivatives were obtained by co-crystallization with <italic>Sp</italic>CBM. Protein solution (33&#160;mg/ml) containing 5&#160;mM ligand was incubated at 4&#160;&#176;C for 30&#160;min followed by mixing with an equal volume of reservoir solution (100&#160;mM MMT pH9.0 and 28&#160;% (w/v) PEG1500). The crystals appeared the next day and reached maximum size in 3&#8211;4 days.</p></sec><sec id="Sec13"><title>X-ray diffraction data collection and processing</title><p>Crystals were cryoprotected by transfer for a few seconds to a solution of the crystallization buffer with 5&#160;% (w/v) ethylene glycol added before data collection at 100&#160;K. All X-ray diffraction data were collected in-house on a Rigaku 007HFM (Cu anode, &#955;&#8201;=&#8201;1.54178) X-ray generator, with a Saturn 944CCD detector. HKL2000 was used for data processing and integration [<xref ref-type="bibr" rid="CR24">24</xref>]. Apo <italic>Sp</italic>CBM crystals belong to the monoclinic space group <italic>P</italic>2<sub>1</sub>, with two monomers in an asymmetric unit. Crystals of complexes were also <italic>P</italic>2<sub>1</sub> but contained one monomer per asymmetric unit. Data collection statistics are given in Table&#160;<xref rid="Tab2" ref-type="table">2</xref>.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Data collection and refinement statistics</p></caption><table-wrap-foot><p>
<sup>a</sup>Numbers in parentheses refer to the highest resolution shell</p><p>
<sup>b</sup>R-merge&#8201;=&#8201;&#931;hkl &#931;i | Ihkl, i -&#8201;&lt;&#8201;Ihkl&#8201;&gt;&#8201;| / &#931;hkl&#8201;&lt;&#8201;Ihkl&gt;</p><p>
<sup>c</sup>R-factor&#8201;=&#8201;(&#931; | |Fo| - |Fc| |) / (&#931; |Fo|)</p><p>
<sup>d</sup>Test set comprised 5&#160;% of reflections</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec14"><title>Structure determination and refinement</title><p>The leech <italic>trans</italic>-sialidase structure [PDB ID: 2SLI] was used to solve the <italic>Sp</italic>CBM structure by molecular replacement with the PHASER program from the CCP4 suite [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>]. Refinement was carried out with the program REFMAC5 [<xref ref-type="bibr" rid="CR27">27</xref>] from the CCP4 suite and the refined model was manually adjusted in Coot [<xref ref-type="bibr" rid="CR28">28</xref>]. After further refinement with REFMAC5, the structures were inspected and validated with Coot and MolProbity [<xref ref-type="bibr" rid="CR29">29</xref>]. Refinement statistics are summarized in Table&#160;<xref rid="Tab2" ref-type="table">2</xref>.</p></sec><sec id="Sec15"><title>Prediction of protein-protein interaction sites</title><p>The meta-PPISP server was used to predict potential protein-protein interaction sites on <italic>Sp</italic>CBM [<xref ref-type="bibr" rid="CR30">30</xref>]. The server combines three different methods in a linear regression analysis, a strategy which improves accuracy compared to the individual methods [<xref ref-type="bibr" rid="CR31">31</xref>&#8211;<xref ref-type="bibr" rid="CR33">33</xref>]. For comparison, the same analysis was carried out on the other family 40 CBMs of known structure.</p></sec></sec><sec id="Sec16"><title>Availability of supporting data</title><p>Coordinates and structure factors have been deposited in the Protein Data Bank with accession numbers 4ZXK, 4C1W and 4CIX for the apo structure, the 3&#8217;SL complex and the 6&#8217;SL complex, respectively.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>NanA</term><def><p>Neuraminidase A</p></def></def-item><def-item><term>CBM</term><def><p>Carbohydrate-Binding Module</p></def></def-item><def-item><term><italic>Sp</italic>CBM</term><def><p><italic>Streptococcus pneumoniae</italic> NanA CBM</p></def></def-item><def-item><term>3&#8217;SL</term><def><p>&#945;2,3-sialyllactose</p></def></def-item><def-item><term>6&#8217;SL</term><def><p>&#945;2,6-sialyllactose</p></def></def-item><def-item><term>hBMECs</term><def><p>human brain microvascular endothelial cells</p></def></def-item><def-item><term>BBB</term><def><p>Blood&#8211;brain-barrier</p></def></def-item><def-item><term>RMSD</term><def><p>Root Mean Square Deviation</p></def></def-item><def-item><term>SPR</term><def><p>Surface Plasmon Resonance</p></def></def-item><def-item><term>BLI</term><def><p>Bio-Layer Interferometry</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Competing interests</bold></p><p>HC and GLT are inventors on a patent held by the University of St Andrews that includes the therapeutic use of <italic>Sp</italic>CBM. LY and JAP declare that they have no competing interests.</p></fn><fn><p><bold>Authors&#8217; contributions</bold></p><p>GLT conceived and coordinated the study. HC, JAP and LY analyzed the structural and affinity data, prepared figures and wrote the manuscript. HC designed and produced the construct for SpNanA CBM expression. LY expressed, purified, crystallized and determined the X-ray structures of SpNanA CBM. All authors reviewed the results and approved the final version of the manuscript.</p></fn></fn-group><ack><title>Acknowledgements</title><p>This research was supported by the University of St Andrews and grants provided by the Medical Research Council. We thank Dr David Robinson at the University of Dundee for assistance in the collection and analysis of Octet data.</p></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jedrzejas</surname><given-names>MJ</given-names></name></person-group><article-title>Pneumococcal virulence factors: structure and function</article-title><source>Microbiology and molecular biology reviews : MMBR</source><year>2001</year><volume>65</volume><issue>2</issue><fpage>187</fpage><lpage>207</lpage><pub-id pub-id-type="doi">10.1128/MMBR.65.2.187-207.2001</pub-id><?supplied-pmid 11381099?><pub-id pub-id-type="pmid">11381099</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pettigrew</surname><given-names>MM</given-names></name><name><surname>Fennie</surname><given-names>KP</given-names></name><name><surname>York</surname><given-names>MP</given-names></name><name><surname>Daniels</surname><given-names>J</given-names></name><name><surname>Ghaffar</surname><given-names>F</given-names></name></person-group><article-title>Variation in the presence of neuraminidase genes among Streptococcus pneumoniae isolates with identical sequence types</article-title><source>Infect Immun</source><year>2006</year><volume>74</volume><issue>6</issue><fpage>3360</fpage><lpage>3365</lpage><pub-id pub-id-type="doi">10.1128/IAI.01442-05</pub-id><?supplied-pmid 16714565?><pub-id pub-id-type="pmid">16714565</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manco</surname><given-names>S</given-names></name><name><surname>Hernon</surname><given-names>F</given-names></name><name><surname>Yesilkaya</surname><given-names>H</given-names></name><name><surname>Paton</surname><given-names>JC</given-names></name><name><surname>Andrew</surname><given-names>PW</given-names></name><name><surname>Kadioglu</surname><given-names>A</given-names></name></person-group><article-title>Pneumococcal neuraminidases A and B both have essential roles during infection of the respiratory tract and sepsis</article-title><source>Infect Immun</source><year>2006</year><volume>74</volume><issue>7</issue><fpage>4014</fpage><lpage>4020</lpage><pub-id pub-id-type="doi">10.1128/IAI.01237-05</pub-id><?supplied-pmid 16790774?><pub-id pub-id-type="pmid">16790774</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tong</surname><given-names>HH</given-names></name><name><surname>Blue</surname><given-names>LE</given-names></name><name><surname>James</surname><given-names>MA</given-names></name><name><surname>DeMaria</surname><given-names>TF</given-names></name></person-group><article-title>Evaluation of the virulence of a Streptococcus pneumoniae neuraminidase-deficient mutant in nasopharyngeal colonization and development of otitis media in the chinchilla model</article-title><source>Infect Immun</source><year>2000</year><volume>68</volume><issue>2</issue><fpage>921</fpage><lpage>924</lpage><pub-id pub-id-type="doi">10.1128/IAI.68.2.921-924.2000</pub-id><?supplied-pmid 10639464?><pub-id pub-id-type="pmid">10639464</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tong</surname><given-names>HH</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>James</surname><given-names>M</given-names></name><name><surname>Demaria</surname><given-names>T</given-names></name></person-group><article-title>Effect of neuraminidase on receptor-mediated adherence of Streptococcus pneumoniae to chinchilla tracheal epithelium</article-title><source>Acta Otolaryngol</source><year>2002</year><volume>122</volume><issue>4</issue><fpage>413</fpage><lpage>419</lpage><pub-id pub-id-type="doi">10.1080/00016480260000111</pub-id><?supplied-pmid 12125999?><pub-id pub-id-type="pmid">12125999</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parker</surname><given-names>D</given-names></name><name><surname>Soong</surname><given-names>G</given-names></name><name><surname>Planet</surname><given-names>P</given-names></name><name><surname>Brower</surname><given-names>J</given-names></name><name><surname>Ratner</surname><given-names>AJ</given-names></name><name><surname>Prince</surname><given-names>A</given-names></name></person-group><article-title>The NanA neuraminidase of Streptococcus pneumoniae is involved in biofilm formation</article-title><source>Infect Immun</source><year>2009</year><volume>77</volume><issue>9</issue><fpage>3722</fpage><lpage>3730</lpage><pub-id pub-id-type="doi">10.1128/IAI.00228-09</pub-id><?supplied-pmid 19564377?><pub-id pub-id-type="pmid">19564377</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shakhnovich</surname><given-names>EA</given-names></name><name><surname>King</surname><given-names>SJ</given-names></name><name><surname>Weiser</surname><given-names>JN</given-names></name></person-group><article-title>Neuraminidase expressed by Streptococcus pneumoniae desialylates the lipopolysaccharide of Neisseria meningitidis and Haemophilus influenzae: a paradigm for interbacterial competition among pathogens of the human respiratory tract</article-title><source>Infect Immun</source><year>2002</year><volume>70</volume><issue>12</issue><fpage>7161</fpage><lpage>7164</lpage><pub-id pub-id-type="doi">10.1128/IAI.70.12.7161-7164.2002</pub-id><?supplied-pmid 12438402?><pub-id pub-id-type="pmid">12438402</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>GY</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>King</surname><given-names>S</given-names></name><name><surname>Cavassani</surname><given-names>KA</given-names></name><name><surname>Cheng</surname><given-names>J</given-names></name><name><surname>Zheng</surname><given-names>X</given-names></name><etal/></person-group><article-title>Amelioration of sepsis by inhibiting sialidase-mediated disruption of the CD24-SiglecG interaction</article-title><source>Nat Biotechnol</source><year>2011</year><volume>29</volume><issue>5</issue><fpage>428</fpage><lpage>435</lpage><pub-id pub-id-type="doi">10.1038/nbt.1846</pub-id><?supplied-pmid 21478876?><pub-id pub-id-type="pmid">21478876</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>King</surname><given-names>SJ</given-names></name><name><surname>Whatmore</surname><given-names>AM</given-names></name><name><surname>Dowson</surname><given-names>CG</given-names></name></person-group><article-title>NanA, a neuraminidase from Streptococcus pneumoniae, shows high levels of sequence diversity, at least in part through recombination with Streptococcus oralis</article-title><source>J Bacteriol</source><year>2005</year><volume>187</volume><issue>15</issue><fpage>5376</fpage><lpage>5386</lpage><pub-id pub-id-type="doi">10.1128/JB.187.15.5376-5386.2005</pub-id><?supplied-pmid 16030232?><pub-id pub-id-type="pmid">16030232</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uchiyama</surname><given-names>S</given-names></name><name><surname>Carlin</surname><given-names>AF</given-names></name><name><surname>Khosravi</surname><given-names>A</given-names></name><name><surname>Weiman</surname><given-names>S</given-names></name><name><surname>Banerjee</surname><given-names>A</given-names></name><name><surname>Quach</surname><given-names>D</given-names></name><etal/></person-group><article-title>The surface-anchored NanA protein promotes pneumococcal brain endothelial cell invasion</article-title><source>J Exp Med</source><year>2009</year><volume>206</volume><issue>9</issue><fpage>1845</fpage><lpage>1852</lpage><pub-id pub-id-type="doi">10.1084/jem.20090386</pub-id><?supplied-pmid 19687228?><pub-id pub-id-type="pmid">19687228</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banerjee</surname><given-names>A</given-names></name><name><surname>Van Sorge</surname><given-names>NM</given-names></name><name><surname>Sheen</surname><given-names>TR</given-names></name><name><surname>Uchiyama</surname><given-names>S</given-names></name><name><surname>Mitchell</surname><given-names>TJ</given-names></name><name><surname>Doran</surname><given-names>KS</given-names></name></person-group><article-title>Activation of brain endothelium by pneumococcal neuraminidase NanA promotes bacterial internalization</article-title><source>Cell Microbiol</source><year>2010</year><volume>12</volume><issue>11</issue><fpage>1576</fpage><lpage>1588</lpage><pub-id pub-id-type="doi">10.1111/j.1462-5822.2010.01490.x</pub-id><?supplied-pmid 20557315?><pub-id pub-id-type="pmid">20557315</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Connaris</surname><given-names>H</given-names></name><name><surname>Govorkova</surname><given-names>EA</given-names></name><name><surname>Ligertwood</surname><given-names>Y</given-names></name><name><surname>Dutia</surname><given-names>BM</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Tauber</surname><given-names>S</given-names></name><etal/></person-group><article-title>Prevention of influenza by targeting host receptors using engineered proteins</article-title><source>Proc Natl Acad Sci U S A</source><year>2014</year><volume>111</volume><issue>17</issue><fpage>6401</fpage><lpage>6406</lpage><pub-id pub-id-type="doi">10.1073/pnas.1404205111</pub-id><?supplied-pmid 24733924?><pub-id pub-id-type="pmid">24733924</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cantarel</surname><given-names>BL</given-names></name><name><surname>Coutinho</surname><given-names>PM</given-names></name><name><surname>Rancurel</surname><given-names>C</given-names></name><name><surname>Bernard</surname><given-names>T</given-names></name><name><surname>Lombard</surname><given-names>V</given-names></name><name><surname>Henrissat</surname><given-names>B</given-names></name></person-group><article-title>The Carbohydrate-Active EnZymes database (CAZy): an expert resource for Glycogenomics</article-title><source>Nucleic Acids Res</source><year>2009</year><volume>37</volume><issue>Database issue</issue><fpage>D233</fpage><lpage>D238</lpage><pub-id pub-id-type="doi">10.1093/nar/gkn663</pub-id><?supplied-pmid 18838391?><pub-id pub-id-type="pmid">18838391</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>G</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Andrew</surname><given-names>PW</given-names></name><name><surname>Taylor</surname><given-names>GL</given-names></name></person-group><article-title>Structure of the catalytic domain of Streptococcus pneumoniae sialidase NanA</article-title><source>Acta Crystallogr, Sect F: Struct Biol Cryst Commun</source><year>2008</year><volume>64</volume><issue>Pt 9</issue><fpage>772</fpage><lpage>775</lpage><pub-id pub-id-type="doi">10.1107/S1744309108024044</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><mixed-citation publication-type="other">Xu G, Kiefel MJ, Wilson JC, Andrew PW, Oggioni MR, Taylor GL. Three Streptococcus pneumoniae Sialidases: Three Different Products. Journal of the American Chemical Society. 2011. doi:10.1021/ja110733q.</mixed-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsiao</surname><given-names>YS</given-names></name><name><surname>Parker</surname><given-names>D</given-names></name><name><surname>Ratner</surname><given-names>AJ</given-names></name><name><surname>Prince</surname><given-names>A</given-names></name><name><surname>Tong</surname><given-names>L</given-names></name></person-group><article-title>Crystal structures of respiratory pathogen neuraminidases</article-title><source>Biochem Biophys Res Commun</source><year>2009</year><volume>380</volume><issue>3</issue><fpage>467</fpage><lpage>471</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2009.01.108</pub-id><?supplied-pmid 19284989?><pub-id pub-id-type="pmid">19284989</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boraston</surname><given-names>AB</given-names></name><name><surname>Ficko-Blean</surname><given-names>E</given-names></name><name><surname>Healey</surname><given-names>M</given-names></name></person-group><article-title>Carbohydrate recognition by a large sialidase toxin from Clostridium perfringens</article-title><source>Biochemistry</source><year>2007</year><volume>46</volume><issue>40</issue><fpage>11352</fpage><lpage>11360</lpage><pub-id pub-id-type="doi">10.1021/bi701317g</pub-id><?supplied-pmid 17850114?><pub-id pub-id-type="pmid">17850114</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>G</given-names></name><name><surname>Potter</surname><given-names>JA</given-names></name><name><surname>Russell</surname><given-names>RJ</given-names></name><name><surname>Oggioni</surname><given-names>MR</given-names></name><name><surname>Andrew</surname><given-names>PW</given-names></name><name><surname>Taylor</surname><given-names>GL</given-names></name></person-group><article-title>Crystal structure of the NanB sialidase from Streptococcus pneumoniae</article-title><source>J Mol Biol</source><year>2008</year><volume>384</volume><issue>2</issue><fpage>436</fpage><lpage>449</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2008.09.032</pub-id><?supplied-pmid 18835278?><pub-id pub-id-type="pmid">18835278</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>SC</given-names></name><name><surname>Chou</surname><given-names>MY</given-names></name><name><surname>Li</surname><given-names>YT</given-names></name><name><surname>Luo</surname><given-names>M</given-names></name></person-group><article-title>The crystal structure of an intramolecular trans-sialidase with a NeuAc alpha2--3Gal specificity</article-title><source>Structure</source><year>1998</year><volume>6</volume><issue>4</issue><fpage>521</fpage><lpage>530</lpage><pub-id pub-id-type="doi">10.1016/S0969-2126(98)00053-7</pub-id><?supplied-pmid 9562562?><pub-id pub-id-type="pmid">9562562</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moustafa</surname><given-names>I</given-names></name><name><surname>Connaris</surname><given-names>H</given-names></name><name><surname>Taylor</surname><given-names>M</given-names></name><name><surname>Zaitsev</surname><given-names>V</given-names></name><name><surname>Wilson</surname><given-names>JC</given-names></name><name><surname>Kiefel</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Sialic acid recognition by Vibrio cholerae neuraminidase</article-title><source>J Biol Chem</source><year>2004</year><volume>279</volume><issue>39</issue><fpage>40819</fpage><lpage>40826</lpage><pub-id pub-id-type="doi">10.1074/jbc.M404965200</pub-id><?supplied-pmid 15226294?><pub-id pub-id-type="pmid">15226294</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Connaris</surname><given-names>H</given-names></name><name><surname>Crocker</surname><given-names>PR</given-names></name><name><surname>Taylor</surname><given-names>GL</given-names></name></person-group><article-title>Enhancing the receptor affinity of the sialic acid-binding domain of Vibrio cholerae sialidase through multivalency</article-title><source>J Biol Chem</source><year>2009</year><volume>284</volume><issue>11</issue><fpage>7339</fpage><lpage>7351</lpage><pub-id pub-id-type="doi">10.1074/jbc.M807398200</pub-id><?supplied-pmid 19124471?><pub-id pub-id-type="pmid">19124471</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Govorkova</surname><given-names>EA</given-names></name><name><surname>Baranovich</surname><given-names>T</given-names></name><name><surname>Marathe</surname><given-names>BM</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Taylor</surname><given-names>MA</given-names></name><name><surname>Webster</surname><given-names>RG</given-names></name><etal/></person-group><article-title>Sialic acid-binding protein Sp2CBMTD protects mice against lethal challenge with emerging influenza A (H7N9) virus</article-title><source>Antimicrob Agents Chemother</source><year>2015</year><volume>59</volume><issue>3</issue><fpage>1495</fpage><lpage>1504</lpage><pub-id pub-id-type="doi">10.1128/AAC.04431-14</pub-id><?supplied-pmid 25534734?><pub-id pub-id-type="pmid">25534734</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Naismith</surname><given-names>JH</given-names></name></person-group><article-title>A simple and efficient expression and purification system using two newly constructed vectors</article-title><source>Protein Expr Purif</source><year>2009</year><volume>63</volume><issue>2</issue><fpage>102</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1016/j.pep.2008.09.008</pub-id><?supplied-pmid 18845260?><pub-id pub-id-type="pmid">18845260</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Otwinowski</surname><given-names>Z</given-names></name><name><surname>Minor</surname><given-names>W</given-names></name></person-group><article-title>Processing of X-ray diffraction data collected in oscillation mode</article-title><source>Method Enzymol</source><year>1997</year><volume>276</volume><fpage>307</fpage><lpage>326</lpage><pub-id pub-id-type="doi">10.1016/S0076-6879(97)76066-X</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCoy</surname><given-names>AJ</given-names></name><name><surname>Grosse-Kunstleve</surname><given-names>RW</given-names></name><name><surname>Adams</surname><given-names>PD</given-names></name><name><surname>Winn</surname><given-names>MD</given-names></name><name><surname>Storoni</surname><given-names>LC</given-names></name><name><surname>Read</surname><given-names>RJ</given-names></name></person-group><article-title>Phaser crystallographic software</article-title><source>J Appl Crystallogr</source><year>2007</year><volume>40</volume><issue>Pt 4</issue><fpage>658</fpage><lpage>674</lpage><pub-id pub-id-type="doi">10.1107/S0021889807021206</pub-id><?supplied-pmid 19461840?><pub-id pub-id-type="pmid">19461840</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winn</surname><given-names>MD</given-names></name><name><surname>Ballard</surname><given-names>CC</given-names></name><name><surname>Cowtan</surname><given-names>KD</given-names></name><name><surname>Dodson</surname><given-names>EJ</given-names></name><name><surname>Emsley</surname><given-names>P</given-names></name><name><surname>Evans</surname><given-names>PR</given-names></name><etal/></person-group><article-title>Overview of the CCP4 suite and current developments</article-title><source>Acta Crystallogr D Biol Crystallogr</source><year>2011</year><volume>67</volume><issue>Pt 4</issue><fpage>235</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.1107/S0907444910045749</pub-id><?supplied-pmid 21460441?><pub-id pub-id-type="pmid">21460441</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murshudov</surname><given-names>GN</given-names></name><name><surname>Vagin</surname><given-names>AA</given-names></name><name><surname>Dodson</surname><given-names>EJ</given-names></name></person-group><article-title>Refinement of macromolecular structures by the maximum-likelihood method</article-title><source>Acta Crystallogr D Biol Crystallogr</source><year>1997</year><volume>53</volume><issue>Pt 3</issue><fpage>240</fpage><lpage>255</lpage><pub-id pub-id-type="doi">10.1107/S0907444996012255</pub-id><?supplied-pmid 15299926?><pub-id pub-id-type="pmid">15299926</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emsley</surname><given-names>P</given-names></name><name><surname>Lohkamp</surname><given-names>B</given-names></name><name><surname>Scott</surname><given-names>WG</given-names></name><name><surname>Cowtan</surname><given-names>K</given-names></name></person-group><article-title>Features and development of Coot</article-title><source>Acta Crystallogr D Biol Crystallogr</source><year>2010</year><volume>66</volume><issue>Pt 4</issue><fpage>486</fpage><lpage>501</lpage><pub-id pub-id-type="doi">10.1107/S0907444910007493</pub-id><?supplied-pmid 20383002?><pub-id pub-id-type="pmid">20383002</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>VB</given-names></name><name><surname>Arendall</surname><given-names>WB</given-names><suffix>3rd</suffix></name><name><surname>Headd</surname><given-names>JJ</given-names></name><name><surname>Keedy</surname><given-names>DA</given-names></name><name><surname>Immormino</surname><given-names>RM</given-names></name><name><surname>Kapral</surname><given-names>GJ</given-names></name><etal/></person-group><article-title>MolProbity: all-atom structure validation for macromolecular crystallography</article-title><source>Acta Crystallogr D Biol Crystallogr</source><year>2010</year><volume>66</volume><issue>Pt 1</issue><fpage>12</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1107/S0907444909042073</pub-id><?supplied-pmid 20057044?><pub-id pub-id-type="pmid">20057044</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname><given-names>S</given-names></name><name><surname>Zhou</surname><given-names>HX</given-names></name></person-group><article-title>meta-PPISP: a meta web server for protein-protein interaction site prediction</article-title><source>Bioinformatics</source><year>2007</year><volume>23</volume><issue>24</issue><fpage>3386</fpage><lpage>3387</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btm434</pub-id><?supplied-pmid 17895276?><pub-id pub-id-type="pmid">17895276</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Zhou</surname><given-names>HX</given-names></name></person-group><article-title>Prediction of interface residues in protein-protein complexes by a consensus neural network method: test against NMR data</article-title><source>Proteins</source><year>2005</year><volume>61</volume><issue>1</issue><fpage>21</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1002/prot.20514</pub-id><?supplied-pmid 16080151?><pub-id pub-id-type="pmid">16080151</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name></person-group><article-title>Protein binding site prediction using an empirical scoring function</article-title><source>Nucleic Acids Res</source><year>2006</year><volume>34</volume><issue>13</issue><fpage>3698</fpage><lpage>3707</lpage><pub-id pub-id-type="doi">10.1093/nar/gkl454</pub-id><?supplied-pmid 16893954?><pub-id pub-id-type="pmid">16893954</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neuvirth</surname><given-names>H</given-names></name><name><surname>Raz</surname><given-names>R</given-names></name><name><surname>Schreiber</surname><given-names>G</given-names></name></person-group><article-title>ProMate: a structure based prediction program to identify the location of protein-protein binding sites</article-title><source>J Mol Biol</source><year>2004</year><volume>338</volume><issue>1</issue><fpage>181</fpage><lpage>199</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2004.02.040</pub-id><?supplied-pmid 15050833?><pub-id pub-id-type="pmid">15050833</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baker</surname><given-names>NA</given-names></name><name><surname>Sept</surname><given-names>D</given-names></name><name><surname>Joseph</surname><given-names>S</given-names></name><name><surname>Holst</surname><given-names>MJ</given-names></name><name><surname>McCammon</surname><given-names>JA</given-names></name></person-group><article-title>Electrostatics of nanosystems: application to microtubules and the ribosome</article-title><source>Proc Natl Acad Sci U S A</source><year>2001</year><volume>98</volume><issue>18</issue><fpage>10037</fpage><lpage>10041</lpage><pub-id pub-id-type="doi">10.1073/pnas.181342398</pub-id><?supplied-pmid 11517324?><pub-id pub-id-type="pmid">11517324</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><mixed-citation publication-type="other">Schrodinger L. The PyMOL Molecular Graphics System, Version 1.3r1. 2010.</mixed-citation></ref></ref-list></back></article>